FireFighterZero
Captain Zero!
Covid antiviral pill can halve risk of hospitalisation
Promising results mean a clinical trial has ended early and emergency authorisation is being sought.www.bbc.com
Be interesting to see what the naysayers make of this.
I think it's interesting because Merck was the company that brought Ivermectin to the market.
Since everyone in the world knows that Ivermectin is absolutely worthless as an antiviral.....Merck probably had to start from scratch and had absolutely NO data whatsoever available when trying to produce an antiviral from scratch.....in absolute record time.